- Home
- MDT vs BMY Comparison
MDT vs BMY Comparison
Compare MDT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDT
- BMY
- Stock Information
- Founded
- MDT 1949
- BMY 1887
- Country
- MDT Ireland
- BMY United States
- Employees
- MDT N/A
- BMY N/A
- Industry
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- MDT Health Care
- BMY Health Care
- Exchange
- MDT Nasdaq
- BMY Nasdaq
- Market Cap
- MDT 114.9B
- BMY 99.7B
- IPO Year
- MDT N/A
- BMY N/A
- Fundamental
- Price
- MDT $93.00
- BMY $48.47
- Analyst Decision
- MDT Buy
- BMY Hold
- Analyst Count
- MDT 17
- BMY 15
- Target Price
- MDT $98.33
- BMY $57.64
- AVG Volume (30 Days)
- MDT 6.3M
- BMY 12.5M
- Earning Date
- MDT 08-19-2025
- BMY 07-31-2025
- Dividend Yield
- MDT 3.05%
- BMY 5.12%
- EPS Growth
- MDT 30.80
- BMY N/A
- EPS
- MDT 3.61
- BMY 2.49
- Revenue
- MDT $33,537,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- MDT $6.33
- BMY N/A
- Revenue Next Year
- MDT $5.26
- BMY N/A
- P/E Ratio
- MDT $25.77
- BMY $19.49
- Revenue Growth
- MDT 3.62
- BMY 2.57
- 52 Week Low
- MDT $79.29
- BMY $42.96
- 52 Week High
- MDT $96.25
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- MDT 61.28
- BMY 58.76
- Support Level
- MDT $91.45
- BMY $44.74
- Resistance Level
- MDT $93.16
- BMY $47.26
- Average True Range (ATR)
- MDT 1.35
- BMY 1.14
- MACD
- MDT 0.06
- BMY 0.33
- Stochastic Oscillator
- MDT 94.43
- BMY 97.18
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.